 Soligenix Inc NASDAQ: SNGX announced the results of a booster vaccination study using CiVax heat-stable COVID-19 subunit vaccine program in non-human primates NHPs. The data demonstrated rapid enhancement of neutralizing antibody responses to SARS-CoV-2, including. 